Ross is specialised in utilising computational technologies to build diagnostic algorithms within cardiovascular imaging. Ross has a strong academic background within the medical sciences and has undertaken two MSc degrees and a DPhil, receiving multiple grants for technology innovation and being selected as finalist for the 2015 Young Investigator Award in Lisbon. Together with Professor Leeson, Ross founded Ultromics’ underlying technology and as CEO, he drives all aspects of the company from technology development to business strategy.
Paul is Professor of Cardiovascular Medicine at the University of Oxford and and Director of the Oxford Cardiovascular Clinical Research Facility. Following a MB/PhD at Cambridge and research at UCL in London, he moved to Oxford and set up a clinical research programme to pioneer the use of novel imaging approaches for prevention of cardiovascular disease. He is also involved in some of the largest cardiovascular imaging research studies in the world and is lead author of Echocardiography, the best selling training handbook for echocardiographers.
Dr. Helen Routh is a global healthcare executive with a record of solving complex problems at the intersection of innovation and business. She has spent much of her career at Philips, in both business and functional roles, building strategies and solutions that combine products, software, and services to improve clinical and operational outcomes. This has included time as the General Manager of Philips Research in North America, as General Manager of Philips’ clinical software divisions, as Senior VP of Strategy and Innovation, leading the development of Innovation Strategy across the company and as head of the Integrated Solutions team.
Dr. Routh currently serves as the chairman of the board of Ultromics, and also works as a strategy advisor for a UK health innovation partnership, linking industry with hospitals, universities, and research. Dr. Routh has a PhD in medical ultrasound, is an invited keynote speaker and panelist on both technical and business topics, and currently serves on the International Scientific Committee of ESPCI in Paris. She lives with her family in the Boston area.
Zachary is Principal at OSI (Oxford Sciences Innovation Plc.) where he works with the University’s world-leading researchers to commercialise and develop the university’s intellectual property into market-leading companies. OSI has raised £580M to build an ecosystem that brings Oxford’s ideas to the world.
Bill’s career spans over 25 years in a broad range of finance positions. Holding a law degree from Cambridge University and as a qualified ACMA, Bill has accumulated international FD/CFO experience in small venture-backed companies, large blue chips and the bio-tech arena.
Bill served as European Finance Director for Visible Genetics, a pioneering company in the field of nucleic acid diagnostics, subsequently holding senior finance positions for Bayer Healthcare in Europe and the USA. Bill played a leading role in securing investment for Oxford University spinout Oxitec and in its successful acquisition by Intrexon Corporation.
Joining Ultromics in February 2018, Bill brings with him extensive experience in life sciences and technology sectors and holds a non-executive directorship at the leading life sciences network, OBN.
Curtis LeBleu is a dynamic marketing executive and recognized commercial leader in the Echocardiography market with over 30 years of commercial ultrasound experience. Curtis lead the development of contrast echocardiography and was previously responsible for the strategy, product definition and launch of the Philips Myocardial Perfusion product. With a strong portfolio of success in strategy development, research, key physician collaboration, marketing and sales, Curtis will oversee commercialization activities including the development of sales, marketing and operations infrastructure.
Deborah uses computational techniques to solve complex scientific challenges, with a specific focus on clinical applications. In addition to a D.Phil. in Mathematical Biology from the University of Oxford and a Bachelor of Science from MIT, Deborah has a range of experience in both academic and commercial settings.
Ed focuses on the use of computational methods for the analysis and visualisation of large clinical and biochemical data sets. Following his PhD and post-doctoral work at Barts and the London School of Medicine and Dentistry, Ed secured a place on the NHS Scientist Training Programme to train as a Clinical Biochemist. He is most interested in the use of machine learning and other computational techniques to unlock the potential of routine clinical laboratory data and is currently undertaking an elective project at Ultromics as part of his training.
Arian focuses on developing computational methods to solve mathematical problems. He has previously worked as a research scientist at King’s College London on optimising medical imaging with MRI. He achieved this using various computational techniques to maximise benefits produced with experimental hardware. Prior to this he completed a PhD in MRI Physics at King’s College London and an MSci in Physics at Imperial College London, with a brief stint in the private sector in between.
Angela utilises machine learning techniques to solve real world problems. During her PhD at Brunel University London she applied reinforcement learning to a complex design problem. More recently she has worked as a postdoctoral research fellow at Brunel University London leading a project to carry out empirical studies in heat transfer. Prior to this she completed an MSc in Engineering Design at Brunel University London and Mechanical engineering at Bachelors level at King’s College London.
Hannah studied Events Management at Leeds Beckett University, upon graduating she was offered a Personal Assistant role at the John Radcliffe Hospital where she worked for two Consultant Thoracic Surgeons. Hannah is now Executive Assistant to Ross Upton, in addition to this she ensures the smooth running of the Ultromics office including operations, finance, personnel and communications.
Ultromics are partnering with Oxford Computer Consultants (OCC) whose Innovation Delivery group specialise in complex engineering software and have a track record in health applications. OCC build commercial applications from research prototypes and will accelerate the delivery of Echuity, bringing a range of skills including UX Design, System Architecture and Application Coding while supporting the growth of Ultromics inhouse teams. The collaboration with OCC is close, and started with the university research group from which Ultromics was formed.
Stay updated with our product launch newsletter
Ultromics is partnered with Oxford Sciences Innovation (OSI)
Ultromics Limited. Registered Office: King Charles House, Park End Street, Oxford, Oxfordshire, United Kingdom, OX1 1JD. Registered No. 10684811.
Copyright © 2017 Ultromics Limited. All rights reserved.